What is the incidence of access site infection following trans-axillary implant of a microaxial left ventricular assist device?
Access site infections occur in approximately 10% of patients requiring extended support with trans-axillary microaxial LVADs, necessitating comprehensive management strategies.
Approximately 10% of patients requiring extended support developed VGI. Heart transplant recipients with a high risk of infection such as extended support or HKT will benefit from a comprehensive approach for early diagnosis and therapeutic intervention.
Shimamura et al. (Mon,) studied this question.